Results 11 to 20 of about 104 (101)

РОЛЬ МИКРОБИОТЫ КИШЕЧНИКА В ПАТОГЕНЕЗЕ БОЛЕЗНИ ПАРКИНСОНА (ЭКСПЕРИМЕНТАЛЬНОЕ ИССЛЕДОВАНИЕ)

Российские биомедицинские исследования, 2021
Болезнь Паркинсона (БП) - экстрапирамидный хронический патологический процесс со специфическими двигательными нарушениями, комплексом немоторных расстройств, сопровождающийся изменением нормальной динамики суточных колебаний большинства физиологических ...
Михаил Сергеевич Некрасов, Илья Олегович Ищенко, Владислав Борисович Царакаев, Алина Денисовна Мочалова, Альбина Сергеевна Могилева, Татьяна Викторовна Брус, Анна Валентиновна Васильева, Андрей Андреевич Лебедев, Сарнг Саналович Пюрвеев   +8 more
doaj  

CUNOȘTINȚE ALE MEDICILOR REFERITOR LA MANAGEMENTUL BOLII PARKINSON ÎN REPUBLICA MOLDOVA

Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale
Boala Parkinson este a doua maladie neurodegenerativă ca frecvență după maladia Alzheimer, cu un mare impact medical, economic și social în lume, inclusiv în Republica Moldova.
Ирина РУСУ, Мэдэлина ЧЕБУК, Оксана ГРОСУ, Галина КОРЧЯ, Лилия РОТАРУ   +4 more
doaj   +1 more source

ДИФФЕРЕНЦИРОВАННОЕ КОМПЛЕКСНОЕ ЛЕЧЕНИЕ ПАЦИЕНТОВ, СТРАДАЮЩИХ БОЛЕЗНЬЮ ПАРКИНСОНА, С УЧЁТОМ СТЕПЕНИ АТРОФИЧЕСКИХ ИЗМЕНЕНИЙ ВЕЩЕСТВА ГОЛОВНОГО МОЗГА

Acta Biomedica Scientifica, 2017
The objective of this study was to compare the results of complex (medicinal and surgical), and only medicinal treatment of patients with rapidly progressive and dyskinesia associated forms of Parkinson's disease.
V. A. Chipizubov, S. I. Petrov, I. M. Mikhalevich   +2 more
doaj   +1 more source

Аналитический обзор речевых и многомодальных методов распознавания когнитивных нарушений людей

Информатика и автоматизация
В течение последнего десятилетия наблюдается рост количества публикаций научно-технической и медицинской направленности, посвящённых автоматическому определению на основании речевого и визуального материала таких когнитивных нарушений людей, которые ...
Mikhail Dolgushin, Alexey Karpov
doaj   +1 more source

Parkinson's disease: a brief overview and clinical observation

Актуальные проблемы теоретической и клинической медицины
Parkinson's disease is the second most common neurodegenerative disease, and its prevalence is projected to double over the next generation. Nevertheless, timely diagnosis of Parkinson's disease remainsa difficult task, and the identification of the ...
M. A. Karzhaubayeva, A. B. Sapargalieva, A. S. Rysbaeva   +2 more
doaj   +1 more source

Diagnosis and treatment of Alzheimer's disease: facets of the problem

Медицинский совет, 2015
Parkinson's disease is a serious, widespread and largely paradoxical neurological disease which still has a lot of "white spots" for research. There is not yet a medication which could prevent death of brain cells and suppress progression of the disease.
Editorial Article
doaj   +1 more source

Parkinson's disease (PD) is the most common neurodegenerative disease

Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, 2015
Metabolic impairment of alpha-synuclein protein is considered to be the central event in PDpathogenesis. Recent studies explored usage of alpha-synuclein in peripheral fluids as a biomarker of PD, however alpha-synuclein level in the CSF and plasma is ...
P. A. Andoskin, A. K. Emelyanov, M. A. Nikolaev, K. A. Senkevich, V. P. Shilin, A. F. Yakimovskiy, A. A. Timofeeva, S. N. Pchelina   +7 more
doaj   +1 more source

Clinical predictors of low quality of life in patients with Parkinson’s disease

Acta Biomedica Scientifica
Background. Despite the comprehensive study of Parkinson’s disease (PD), studying the quality of life (QoL) of patients, especially the prediction of low QoL, remains an unresolved issue.The aim.
L. I. Kopylova, A. A. Tappakhov, T. Ya. Nikolaeva   +2 more
doaj   +1 more source

Mobile computer technologies in personified therapy of Parkinson’s disease patients

Acta Biomedica Scientifica, 2018
Parkinson's disease is a long-term degenerative disorder of the central nervous system. Parkinson's disease typically occurs in people over the age of 60, of which about one percent are affected.
Y. N. Bykov, T. B. Bender
doaj   +1 more source

Depression in Parkinson's disease as the key factor of deterioration in quality of life: pathophysiology, diagnostics and treatment

Медицинский совет, 2013
Parkinson's disease (PD) is multisystem neurodegenerative disorder with a wide range of motor, nervous and mental disorders. On average, depression occurs in 40-50% of patients with Parkinson's disease and is a major factors of deterioration of life ...
M. R. Nodel
doaj   +1 more source